These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6624710)

  • 1. Assay of Factor XII clotting activity in heparinized plasma.
    Lämmle B; Tran TH; Duckert F
    Am J Clin Pathol; 1983 Oct; 80(4):474-7. PubMed ID: 6624710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial thromboplastin time in the presence of heparin: a rapid polybrene neutralization method.
    Israels ED
    Am J Clin Pathol; 1982 Mar; 77(3):321-4. PubMed ID: 6803572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
    Tientadakul P; Kongkan C; Chinswangwatanakul W
    Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: an assessment of four heparin antagonists and two anion exchange resins.
    Cumming AM; Jones GR; Wensley RT; Cundall RB
    Thromb Res; 1986 Jan; 41(1):43-56. PubMed ID: 3961726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factor XII (Hageman factor)].
    Saito H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():657-9. PubMed ID: 15658416
    [No Abstract]   [Full Text] [Related]  

  • 7. Hageman factor deficiency presentation and implications for management.
    Harper K; Friedland ML
    Conn Med; 1992 Sep; 56(9):469-71. PubMed ID: 1424610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The assay of factor VIII: C in heparinized plasma: a polybrene neutralization method.
    Cumming AM; Wensley RT; Delamore IW
    Thromb Haemost; 1986 Feb; 55(1):58-60. PubMed ID: 3085265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of plasma heparin by polybrene neutralization.
    Nash PV; Bjornsson TD
    Anal Biochem; 1984 May; 138(2):319-23. PubMed ID: 6742408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of factor XII analysis in blood coagulation tests].
    Saito H
    Nihon Rinsho; 1989 Dec; 48 Suppl():843-5. PubMed ID: 2622016
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.
    van Veen JJ; Laidlaw S; Swanevelder J; Harvey N; Watson C; Kitchen S; Makris M
    Eur J Haematol; 2009 Mar; 82(3):208-12. PubMed ID: 19077049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method for evaluation of blood coagulation in heparinized blood.
    Cowan JF; Khan MB; Vargo J; Joist JH
    Am J Clin Pathol; 1981 Jan; 75(1):60-4. PubMed ID: 7457430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma heparin: a simple, one-sample determination of both effect and concentration based on the activated partial thromboplastin time.
    Hoffman JJ; Meulendijk PN
    Clin Chim Acta; 1978 Aug; 87(3):417-24. PubMed ID: 679478
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of hexadimethrine bromide as a heparin-neutralizing agent in canine plasma.
    Green RA; LaFollette KA; Greig B
    Am J Vet Res; 1987 Mar; 48(3):496-8. PubMed ID: 3565907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of calcium ions on the activated partial thromboplastin time of heparinized plasma.
    Greenberg CS; Adams JP; Mullen PE; Koepke JA
    Am J Clin Pathol; 1986 Oct; 86(4):484-9. PubMed ID: 3766461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of in vitro thrombin generation after neutralization of heparin.
    Hardy M; Douxfils J; Morimont L; Didembourg M; Carlo A; de Maistre E; Lecompte T; Mullier F
    Int J Lab Hematol; 2022 Feb; 44(1):168-176. PubMed ID: 34582127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired factor XII deficiency following transanal excision of rectal lesion by transanal minimally invasive surgery (TAMIS): a case report and literature review.
    Cozzi MR; Lauretta A; Vettori R; Steffan A
    World J Surg Oncol; 2018 Jun; 16(1):115. PubMed ID: 29921296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new principle in heparin assaying based on partial neutralization of heparin with polybrene.
    Talstad I
    Thromb Res; 1980 May 1-15; 18(3-4):485-91. PubMed ID: 7414543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.